FDAnews
www.fdanews.com/articles/177787-two-btg-products-get-ce-mark-reclassifications-as-class-iii-devices

Two BTG Products Get CE Mark Reclassifications as Class III Devices

August 2, 2016

DC Bead and DC Bead M1 have been reclassified as Class III medical devices.

These devices are embolic drug-eluting beads capable of loading and releasing compatible chemotherapeutic agents.

These drug administrators are the only drug-eluting beads with CE Mark approval for filling with doxorubicin and irinotecan, according to the company. — Cynthia Jessup

View today's stories